X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (20) 20
breast cancer (17) 17
index medicus (16) 16
humans (13) 13
female (12) 12
cancer (11) 11
article (8) 8
breast neoplasms - drug therapy (8) 8
chemotherapy (8) 8
medicine & public health (8) 8
metastasis (8) 8
fulvestrant (7) 7
aged (6) 6
breast neoplasms - pathology (6) 6
middle aged (6) 6
tumors (6) 6
adult (5) 5
endocrine therapy (5) 5
erbb-2 protein (5) 5
patients (5) 5
aged, 80 and over (4) 4
animals (4) 4
breast (4) 4
cancer research (4) 4
deoxyribonucleic acid--dna (4) 4
drug resistance (4) 4
estrogen (4) 4
estrogen-receptor (4) 4
estrogens (4) 4
gene sequencing (4) 4
genes (4) 4
her2 (4) 4
neoplasm staging (4) 4
postmenopausal women (4) 4
research (4) 4
adjuvant treatment (3) 3
anastrozole (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - metabolism (3) 3
care and treatment (3) 3
cell line, tumor (3) 3
cells (3) 3
development and progression (3) 3
double-blind (3) 3
drug resistance, neoplasm (3) 3
gene expression (3) 3
hematology, oncology and palliative medicine (3) 3
inhibition (3) 3
inhibitors (3) 3
lapatinib (3) 3
metastases (3) 3
mutation (3) 3
neoplasm metastasis (3) 3
receptor, erbb-2 - metabolism (3) 3
tamoxifen (3) 3
transcription (3) 3
trastuzumab (3) 3
treatment outcome (3) 3
tyrosine (3) 3
women (3) 3
akt (2) 2
amplification (2) 2
analysis (2) 2
antagonists (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
aromatase (2) 2
aromatase inhibition (2) 2
breast neoplasms - mortality (2) 2
breast neoplasms - surgery (2) 2
cancer therapies (2) 2
chemotherapy, adjuvant (2) 2
clinical trials (2) 2
combination (2) 2
conversion (2) 2
cyclin-dependent kinase 4 (2) 2
deprivation (2) 2
diagnosis (2) 2
disease (2) 2
disease-free survival (2) 2
dna sequencing (2) 2
dose-response relationship, drug (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
efficacy (2) 2
estrogen receptor alpha - metabolism (2) 2
estrogen receptors (2) 2
experimental design (2) 2
expression (2) 2
fibroblast growth factor receptor 1 (2) 2
fibroblast growth factor receptors (2) 2
follow-up (2) 2
follow-up studies (2) 2
gene expression regulation, neoplastic (2) 2
genetic aspects (2) 2
growth-factor receptor (2) 2
hera trial (2) 2
kaplan-meier estimate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer discovery, ISSN 2159-8274, 02/2019, Volume 9, Issue 2, pp. 304 - 304
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
Cancer Discovery, ISSN 2159-8274, 2017, Volume 7, Issue 6, pp. 561 - 574
Journal Article
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
Cell Metabolism, ISSN 1550-4131, 10/2017, Volume 26, Issue 4, pp. 633 - 647.e7
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 20, pp. 6138 - 6151
Purpose: FGFR1 amplification occurs in approximately 15% of estrogen receptor-positive (ER+) human breast cancers. Weinvestigated mechanisms by which FGFR1... 
AMPLIFICATION | PROTEIN | ONCOLOGY | THERAPEUTIC TARGET | GENES | ENDOCRINE THERAPY | FACTOR RECEPTOR-1 | FIBROBLAST-GROWTH-FACTOR | SIGNALING MODULE | EXPRESSION | NUCLEAR TRANSLOCATION | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Fibroblast Growth Factors - genetics | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Estrogen Receptor alpha - metabolism | Female | Transcription, Genetic | Disease Models, Animal | Estrogen Receptor alpha - antagonists & inhibitors | Breast Neoplasms - drug therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Estrogen Receptor Modulators - pharmacology | Protein Transport | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Gene Amplification | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasm Staging | Cell proliferation | Fibroblast growth factor | Transcription | Genes | Estrogens | Estrogen | Estrogen receptors | Antagonists | Kinases | Nuclei | Fulvestrant | Gene sequencing | E2F protein | Surgery | Xenografts | Inhibition | Fibroblast growth factor receptor 1 | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Binding | Tyrosine | Deprivation | Breast cancer | siRNA | Gene expression | Patients | Polymerase chain reaction | Amplification | Ribonucleic acids | Experimental design | Breast | Ligands | Nuclei (cytology) | Tumors | Cancer | Fibroblast growth factor receptors | breast cancer | drug resistance | fulvestrant | FGFR1
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4508 - 4508
Hypothesis: Approximately 20 of patients with early ER breast cancer (BC) treated with adjuvant antiestrogen therapy eventually relapse with... 
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 01/2019, Volume 25, Issue 2, pp. 771 - 783
Purpose: The phase III ExteNET trial showed improved invasive disease- free survival in patients with HER2(+) breast cancer treated with neratinib versus... 
GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | TRASTUZUMAB | EFFICACY | ONCOLOGY | CYCLIN D1 | TAMOXIFEN RESISTANCE | DOUBLE-BLIND | TYROSINE KINASE INHIBITOR | PHASE-II | COMBINATION | breast cancer | neratinib | HER2 | fulvestrant
Journal Article
Journal Article